Literature DB >> 35876596

Chemsex users in Czechia: EMIS survey.

Xenie Uholyeva1, Michal Pitoňák2.   

Abstract

OBJECTIVES: Chemsex is a phenomenon highly relevant to public health concerns. Our primary aim is to describe the Czech chemsex scene regarding substances used, sexual behaviour, mental health, sexual life satisfaction, internalization of homonegative attitudes, and prevalent chemsex patterns.
METHODS: The data from the European Men Who Have Sex With Men Internet Survey (EMIS) 2017 were used. The mental health of chemsex users was assessed by the Patient Health Questionnaire 4 (PHQ4), internalized homonegativity was measured using the Short Internalized Homonegativity Scale. A sample of 87 men who have sex with men (MSM) chemsex users and a comparison group of 261 MSM were selected from the total sample of 1,688 respondents. Mann-Whitney and χ2 tests were used to compare groups.
RESULTS: Active chemsex users made up 5% of the sample (87 of 1,688), with an average age of 37 years. Chemsex users were more likely to engage in condomless sex with non-steady partners (χ2 = 46.8, p < 0.001), and had dramatically more STIs, such as HIV (χ2 = 52.9, p < 0.001), HCV (χ2 = 25.9, p < 0.001), and syphilis (χ2 = 41.5, p < 0.001). Chemsex users frequently injected drugs (n = 19, 20%). More than half (n = 48; 55%) of chemsex users had sober sex in the last 4 weeks. Chemsex culture was associated with riskier substance use, both in terms of mode and frequency. The mental health of chemsex users in our sample did not differ significantly from the comparison group (χ2 = 0.2, p < 0.7). Chemsex users did not conceal their sexual identity more often than the comparison group, on the contrary, 69% (n = 59) of them were out to most significant others, compared to 53% (n = 134) in the comparison group (χ2 = 8.8, p < 0.05). In addition, we did not find differences in the degree of internalized homonegativity (χ2 = 0.9, p < 0.4). Chemsex users were clearly and significantly more satisfied with their sex life than the comparison group (Mann-Whitney U test, p < 0.001).
CONCLUSIONS: In our sample, chemsex use was not associated with a negative impact on health or wellbeing. Our results suggest that chemsex is not a homogeneous phenomenon. Many different patterns and subcultures exist, some of them are riskier, some safer than others.

Entities:  

Keywords:  MSM; chemsex; internalized homonegativity; sexual satisfaction; sober sex

Mesh:

Year:  2022        PMID: 35876596     DOI: 10.21101/cejph.a6923

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.154


  23 in total

1.  Chemsex behaviours among men who have sex with men: A systematic review of the literature.

Authors:  Steven Maxwell; Maryam Shahmanesh; Mitzy Gafos
Journal:  Int J Drug Policy       Date:  2018-12-01

2.  Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey.

Authors:  Magdalena Rosińska; Lorenzo Gios; Christiana Nöstlinger; Wim Vanden Berghe; Ulrich Marcus; Susanne Schink; Nigel Sherriff; Anna-Marie Jones; Cinta Folch; Sonia Dias; Inga Velicko; Massimo Mirandola
Journal:  Int J Drug Policy       Date:  2018-05-07

Review 3.  Sexualised drug use in the United Kingdom (UK): A review of the literature.

Authors:  Claire Edmundson; Ellen Heinsbroek; Rachel Glass; Vivian Hope; Hamish Mohammed; Martin White; Monica Desai
Journal:  Int J Drug Policy       Date:  2018-04-04

4.  Do men who have sex with men who report alcohol and illicit drug use before/during sex (chemsex) present moderate/high risk for substance use disorders?

Authors:  Thiago S Torres; Leonardo S Bastos; Luciana Kamel; Daniel R B Bezerra; Nilo M Fernandes; Ronaldo I Moreira; Alex Garner; Valdilea G Veloso; Beatriz Grinsztejn; Raquel B De Boni
Journal:  Drug Alcohol Depend       Date:  2020-02-11       Impact factor: 4.492

5.  Drug use among men who have sex with men in Ireland: Prevalence and associated factors from a national online survey.

Authors:  P Barrett; K O'Donnell; M Fitzgerald; A J Schmidt; F Hickson; M Quinlan; P Keogh; L O'Connor; D McCartney; D Igoe
Journal:  Int J Drug Policy       Date:  2018-12-02

6.  Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.

Authors:  B Hampel; K Kusejko; R D Kouyos; J Böni; M Flepp; M Stöckle; A Conen; C Béguelin; P Künzler-Heule; D Nicca; A J Schmidt; H Nguyen; J Delaloye; M Rougemont; E Bernasconi; A Rauch; H F Günthard; D L Braun; J Fehr
Journal:  HIV Med       Date:  2019-12-18       Impact factor: 3.180

7.  Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland.

Authors:  Ronan W Glynn; Niamh Byrne; Siobhan O'Dea; Adam Shanley; Mary Codd; Eamon Keenan; Mary Ward; Derval Igoe; Susan Clarke
Journal:  Int J Drug Policy       Date:  2017-12-07

8.  Destabilising the 'problem' of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use.

Authors:  Kerryn Drysdale; Joanne Bryant; Max Hopwood; Gary W Dowsett; Martin Holt; Toby Lea; Peter Aggleton; Carla Treloar
Journal:  Int J Drug Policy       Date:  2020-02-14

9.  Latent classes of sexual risk and corresponding STI and HIV positivity among MSM attending centres for sexual health in the Netherlands.

Authors:  Isabel A L Slurink; Birgit H B van Benthem; Martijn S van Rooijen; Roel C A Achterbergh; Fleur van Aar
Journal:  Sex Transm Infect       Date:  2019-06-20       Impact factor: 3.519

10.  Characteristics and sexual health service use of MSM engaging in chemsex: results from a large online survey in England.

Authors:  Paula Bianca Blomquist; Hamish Mohammed; Amy Mikhail; Peter Weatherburn; David Reid; Sonali Wayal; Gwenda Hughes; Catherine H Mercer
Journal:  Sex Transm Infect       Date:  2020-03-05       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.